World Congress On Ovulation induction & Ovarian stimulation protocols is nothing but a meeting or gathering of physicians (practicing ART). They discuss various ways through which specialist can predict ovarian response in a better way for the stimulation with the help of gonadotropins.
Physicians also make discussion on the selection of the ideal stimulation protocol and customize it for each and every patient separately. Topics of this meeting include the following:
- Evolution procedure of ovulation induction for In vitro fertilization (IVF)
- Proper protocols for inferior responders
- Appropriate strategies to prevent OHSS (ovarian hyperstimulation syndrome)
- Ovulation induction for onco-fertility patients
- Ovarian reserve testing
Controlled Ovarian Stimulation (COS) with gonadotropins to produce multiple follicular development and high-quality oocytes is the cornerstone of Assisted Reproductive technology. Today, Recombinant human follicle-stimulating hormone (r-hFSH) as well as Biosimilars are widely used for COS. A long-acting r-hFSH and a combination of r-hFSH and recombinant human luteinizing hormone have recently become available. Formulations of purified urinary FSH with or without luteinizing hormone activity (provided by human chorionic gonadotropin) are also available. COS protocols can now be individualized to optimize efficacy and safety – defined as euploid singleton pregnancies with a low incidence of ovarian hyperstimulation syndrome. This is facilitated by an estimation of ovarian response using the antral follicle count and/or serum anti-Müllerian hormone levels; anti-Müllerian hormone is viewed as the most reliable single marker. However, an efficient management strategy for poor responders to COS is still required. Developments in Biomarkers and other techniques for accurate identification of viable oocytes and embryos and optimal uterine receptivity are expected.
Special emphasis needs to be given on how to avoid excessive response and predict the occurrence of Ovarian Hyperstimulation Syndrome (OHSS), as well as on maximizing tolerability of treatment from a patient’s perspective.
The duration of the World Congress on Ovulation Induction and Ovarian Stimulation Protocols is four days. This prominent IVF Fertility conference is very helpful for attendees in acquiring adequate knowledge about the several aspects related to ovarian stimulation as well as ovulation induction.
Attendees will get in-depth knowledge about the technological developments linked with several complications of ovarian stimulation, ovulation induction as well as scientific solution to such problems. In a nutshell, this conference is very significant to address some serious issues in today’s world.
The conference is preceded by both International speakers and the Indian speakers. The participants include Embryologist, Gynecologist, Fertility Experts, and all those physicians, who practice ART, will be capable of discussing different ways in which specialists might assume the ovarian response to the stimulation with gonadotropins and choose the appropriate stimulation protocol and customize it to each and every patient.
The attendees of this conference also discuss the mild stimulation as well as financial implications, IVF treatment segmentation, emergency stimulation for oncofertility patients, Primary, secondary and tertiary prevention of ovarian hyperstimulation syndrome.
This type of global conference is highly appreciated and required in today’s world so that more and more health complications can be addressed.